Dr. Plevy is a gastroenterologist and molecular immunologist. He most recently served as chief scientific officer at biotechnology company Senda Biosciences and has previously held leadership positions at Janssen Pharmaceuticals and Synlogic Therapeutics. He has published more than 110 peer-reviewed papers on immunologic disorders, including those related to inflammatory bowel disease.
Dr. Plevy received his medical degree from Columbia University in New York City and completed his residency at Brigham and Women’s Hospital in Boston.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
